These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19699431)

  • 1. Tetanus, diphtheria, and acellular pertussis vaccine: a position statement of the Society for Adolescent Medicine.
    Middleman AB; Bruner A
    J Adolesc Health; 2009 Sep; 45(3):316-7. PubMed ID: 19699431
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
    Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: reassurance for the future.
    Halperin SA
    J Pediatr; 2006 Nov; 149(5):589-91. PubMed ID: 17095321
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
    Gidengil CA; Sandora TJ; Lee GM
    Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information for parents. Tdap vaccine for preteens and teens.
    J Okla State Med Assoc; 2013 Aug; 106(8):326. PubMed ID: 24245439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diphtheria--tetanus--pertussis].
    Gasparini R; Marensi L; Basso G
    Pediatr Med Chir; 1994; 16(4):377-85. PubMed ID: 7816702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.
    Kirkland KB; Talbot EA; Decker MD; Edwards KM
    Clin Infect Dis; 2009 Aug; 49(4):584-7. PubMed ID: 19589084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Four years of experience with diphtheria-pertussis-tetanus vaccination: 1000 cases].
    MAZA PEREZ C
    Rev Cubana Pediatr; 1954 Aug; 26(8):531-8. PubMed ID: 13224977
    [No Abstract]   [Full Text] [Related]  

  • 11. Statement on the recommended use of pentavalent and hexavalent vaccines. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Feb; 33(ACS-1):1-14. PubMed ID: 17294559
    [No Abstract]   [Full Text] [Related]  

  • 12. Pertussis vaccines for adolescents and adults.
    Cherry JD
    Pediatrics; 2005 Sep; 116(3):755-6. PubMed ID: 16140719
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization against diphtheria, pertussis and tetanus.
    Rubio T
    J Okla State Med Assoc; 1969 Mar; 62(3):100-2. PubMed ID: 5774602
    [No Abstract]   [Full Text] [Related]  

  • 14. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.
    Robbins JB; Schneerson R; Trollfors B; Sato H; Sato Y; Rappuoli R; Keith JM
    J Infect Dis; 2005 Jan; 191(1):81-8. PubMed ID: 15593007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse events after administration of tetanus-diphtheria-acellular pertussis vaccine to healthcare workers.
    Sandora TJ; Pfoh E; Lee GM
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):389-91. PubMed ID: 19239376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphtheria, tetanus, and pertussis vaccine.
    Md State Med J; 1970 Feb; 19(2):83. PubMed ID: 5411843
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction of tetanus toxoid and reduced diphtheria toxoid vaccines in the United States.
    Mink CM
    Pediatr Infect Dis J; 2006 Apr; 25(4):363-4. PubMed ID: 16567991
    [No Abstract]   [Full Text] [Related]  

  • 19. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.
    Pichichero ME; DeTora LM; Johnson DR
    Expert Rev Vaccines; 2006 Apr; 5(2):175-87. PubMed ID: 16608418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendation of the Immunization Practices Advisory Committee (ACIP). Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Aug; 30(32):392-6, 401-7. PubMed ID: 6790932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.